R. Lucas (Konstanz, Germany), D. Olivieri (Parma, Italy)
Polymorphism of NRAMP1 gene in chronic obstructive pulmonary disease patients
G. N. Seitova, E. B. Bukreeva, O. Y. Bychkova, E. A. Dementieva, S. V. Nesterovich, V. P. Puzyrev (Tomsk, Russia)
|  |
The role of 774C/T, -691C/T and 894G/T polymorphisms of NOS3 gene in development of COPD
G. N. Seitova, E. B. Bukreeva, O. Y. Bychkova, E. A. Dementieva, S. V. Nesterovich, V. P. Puzyrev (Tomsk, Russia)
| |
No association of interleukin-8 gene polymorphism and COPD in Russians ant Siberian Tatars
G. N. Seitova, E. B. Bukreeva, O. Y. Bychkova, E. A. Dementieva, S. V. Nesterovich, O. E. Akbasheva, V. P. Puzyrev (Tomsk, Russia)
| |
Evaluation of endothelial dysfunction at the patients with COPD
N. Karoli, A. Rebrov (Saratov, Russia)
| |
Endothelial dysfunction, smoking and COPD
N. Karoli, A. Rebrov (Saratov, Russia)
| |
Circulating adhesion molecules in patients with chronic obstructive pulmonary disease
A. S. Yurdakul, N. T. Hoca, F. Cimen, M. Balci, S. Atikcan (Ankara, Turkey)
| |
Membrane-receptor disorders in COPD
N. I. Zoirova, S. I. Arifkhanova (Tashkent, Uzbekistan)
| |
Inflammatory cell counts in induced sputum from non-allergic asthmatics and COPD patients
B. Sitkauskiene, A. Krisiukeniene, K. Malakauskas, R. Sakalauskas (Kaunas, Lithuania)
| |
Increased propensity for apoptosis and decreased Bcl-2 in peripheral blood T-cells from COPD patients - effect of corticosteroids?
S. J. Hodge, G. L. Hodge, H. Mark, R. N. Paul (Adelaide, Australia)
| |
Nitrite concentration in exhaled breath condensate correlates with markers of lung overdistension in COPD
C. Gessner, S. Hammerschmidt, R. Scheibe, H. Kuhn, U. Sack, H. Wirtz (Leipzig, Germany)
| |
Evaluation of a new easy-to-use method for large scale determination of glucocorticoid receptor activity
M. C. Gencay, J. J. Rüdiger, J. Q. Yang, M. Tamm, M. Roth (Basel, Switzerland; Sydney, Australia)
| |
Ligand independent activation of the glucocorticoid receptor by long acting β2 agonists
C. Lambers, R. Ziesche, V. Petkov, L. H. Block (Vienna, Austria)
| |
Anti-inflammatory function of tiotropium mediated by suppression of acetylcholine-induced release of chemotactic activity
F. Bühling, N. Lieder, A. Reisenauer, T. Welte (Magdeburg, Germany)
| |
Telomere shortening in alveolar macrophages from young smokers
K. Tomita, Y. Hasegawa, K. Iwata, M. Watanabe, H. Sano, Y. Hitsuda, E. Shimizu (Yonago, Japan)
| |
Microsatellite analysis of induced sputum DNA in normal subjects
A. Castagnaro, A. Verduri, G. Di Cola, R. D‘Ippolito, M. Maestrelli, F. Fontana, A. Foresi, E. Marangio, A. Chetta, M. Del Donno, D. Olivieri (Parma, Sesto S. Giovanni, Italy)
| |
Expression of monocyte chemoattractant protein–1 (MCP-1) and CC chemokine receptor 2 (CCR2B) by purified blood monocytes in smokers with lung cancer
I. Bononi, D. Miotto, G. F. Milani, C. Legorini, G. Cavallesco, I. Guzzinati, R. Rizzo, P. Boschetto, L. M. Fabbri, C. E. Mapp (Ferrara, Rovigo, Modena, Italy)
| |
The levels of osteoprotegerin (OPG), interleukin 18 (IL-18) and soluble interleukin 2 receptor (sIL-2R) in serum during chemotherapy of lung cancer
W. Naumnik, E. Chyczewska, T. Izycki (Bialystok, Poland)
| |
The clinical significance of serum osteoprotegerin (OPG) and pro-gastrin-releasing peptide (ProGRP) concentrations in lung cancer
W. Naumnik, E. Chyczewska, T. Izycki, B. Panek-Penpicka, M. Ossolinska (Bialystok, Poland)
| |
Apoptosis activated T- lymphocytes in induced sputum (IS) of patients with chronic obstructive bronchitis (COB)
S. A. Pazych, V. A. Nevzorova (Vladivostok, Russia)
| |